Combinib 250 mg (Lapatinib ditosylate) Exporter | India Supplier – City Drug Exporters Combinib 250 mg (Lapatinib ditosylate).
City Drug Exporters supplies genuine pharma Products with bulk supply & global delivery
1.Mechanism of Action: It is a dual tyrosine kinase inhibitor that interrupts the HER2 (human epidermal growth factor receptor 2) and EGFR (epidermal growth factor receptor) pathways. By inhibiting these, it prevents cancer cell multiplication, particularly in HER2-overexpressing tumors.
2.Indications: Used in combination with other chemotherapy agents (like capecitabine) for advanced or metastatic HER2-positive breast cancer.
3.Dosage and Administration: Typically taken orally once daily, usually 1250 mg (5 tablets) in combination with other medicines. It is crucial to take this on an empty stomach, at least one hour before or two hours after a meal.
4.Common Side Effects: Diarrhea (very common), nausea, vomiting, rash, dry skin, fatigue, anorexia, and stomatitis.
City Drug Exporters is a trusted Indian pharmaceutical exporter supplying Combinib 250 mg (Lapatinib ditosylate) in bulk quantities to international markets with strict quality control and regulatory compliance.
Combinib 250 mg (Lapatinib ditosylate) Supplier, Dealer, Exporter
We City drug house exporters Is The Leading Supplier, Dealer, Exporter For Combinib 250 mg (Lapatinib ditosylate) In washington, USA and Nagpur INDIA.
